SEC Form 4 · accession 0000914190-16-000795
NEPHROS INC · NEPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Moshe Pinto
Director
Period of report
Aug 24, 2016
Accepted (ET)
Aug 26, 2016 · 5:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001196298
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 24, 2016 | A | 73,864 | $0.00 | A | 82,581 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $0.40 | Aug 24, 2016 | A | 33,880 | A | — | Aug 24, 2026 | Common Stock | 33,880 | 33,880 | D |
| Stock Option (Right to Buy)F2 | $0.45 | holding | — | — | — | — | Aug 14, 2025 | Common Stock | 59,155 | 59,155 | D |
Explanation of responses
- F1On August 24, 2016, the Company granted 73,864 shares of restricted stock of the Company (the "Restricted Stock") in lieu of $26,000 in cash fees payable to Mr. Pinto in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). The Restricted Stock vests 6 months following the grant date.
- F2The option vests as to 19,719 shares on 8/14/16 and as to 19,718 shares on each of 8/14/17 and 8/14/18.
- F3On August 24, 2016, the Company granted an option to purchase 33,880 shares of common stock of the Company (the "Option") in respect of the service by Mr. Pinto as a member of the Board of Directors of the Company. The Option was granted under the 2015 Plan. This option vests as to 11,294 shares on 8/24/16 and as to 11,293 shares on each of 8/24/17 and 8/24/18.